127 related articles for article (PubMed ID: 33909462)
1. Diagnostic Accuracy of MRI for the Detection of Malignant Peripheral Nerve Sheath Tumors: A Systematic Review and Meta-Analysis.
Wilson MP; Katlariwala P; Low G; Murad MH; McInnes MDF; Jacques L; Jack AS
AJR Am J Roentgenol; 2021 Jul; 217(1):31-39. PubMed ID: 33909462
[No Abstract] [Full Text] [Related]
2. The role of magnetic resonance imaging in the diagnostic evaluation of malignant peripheral nerve sheath tumors.
Chhabra A; Soldatos T; Durand DJ; Carrino JA; McCarthy EF; Belzberg AJ
Indian J Cancer; 2011; 48(3):328-34. PubMed ID: 21921333
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Ristow I; Madesta F; Well L; Shenas F; Wright F; Molwitz I; Farschtschi S; Bannas P; Adam G; Mautner VF; Werner R; Salamon J
Neuro Oncol; 2022 Oct; 24(10):1790-1798. PubMed ID: 35426432
[TBL] [Abstract][Full Text] [Related]
4. Peripheral nerve sheath tumor: differentiation of malignant from benign tumors with conventional and diffusion-weighted MRI.
Yun JS; Lee MH; Lee SM; Lee JS; Kim HJ; Lee SJ; Chung HW; Lee SH; Shin MJ
Eur Radiol; 2021 Mar; 31(3):1548-1557. PubMed ID: 32894357
[TBL] [Abstract][Full Text] [Related]
5. Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center: Value of Clinical and Ultrasound Features for the Diagnosis of Malignant Peripheral Nerve Sheath Tumor Compared With Magnetic Resonance Imaging.
Jin Z; Wang C; Wang D; Li X; Guo W; Chen T
J Ultrasound Med; 2024 Jan; 43(1):21-31. PubMed ID: 37772628
[TBL] [Abstract][Full Text] [Related]
6. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging.
Ahlawat S; Fayad LM
Eur J Radiol; 2018 May; 102():195-201. PubMed ID: 29685535
[TBL] [Abstract][Full Text] [Related]
7. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
Ristow I; Kaul MG; Stark M; Zapf A; Riedel C; Lenz A; Mautner VF; Farschtschi S; Apostolova I; Adam G; Bannas P; Salamon J; Well L
Neurooncol Adv; 2024; 6(1):vdae021. PubMed ID: 38468867
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of CT and MR features for detecting atypical lipomatous tumors and malignant liposarcomas: a systematic review and meta-analysis.
Wilson MP; Haidey J; Murad MH; Sept L; Low G
Eur Radiol; 2023 Dec; 33(12):8605-8616. PubMed ID: 37439933
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imaging.
Well L; Salamon J; Kaul MG; Farschtschi S; Herrmann J; Geier KI; Hagel C; Bockhorn M; Bannas P; Adam G; Mautner VF; Derlin T
Neuro Oncol; 2019 Mar; 21(4):508-516. PubMed ID: 30496452
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Quality of Magnetic Resonance Imaging Interpretation for Peripheral Nerve Sheath Tumors: Can Malignancy Be Determined?
Karsy M; Guan J; Ravindra VM; Stilwill S; Mahan MA
J Neurol Surg A Cent Eur Neurosurg; 2016 Nov; 77(6):495-504. PubMed ID: 27276118
[No Abstract] [Full Text] [Related]
11. Magnetic Resonance Imaging Features for Differentiating Low-Grade and High-Grade Malignant Peripheral Nerve Sheath Tumors.
Yamada N; Kato H; Kawaguchi M; Suzui N; Miyazaki T; Nagano A; Noda Y; Hyodo F; Matsuo M
J Comput Assist Tomogr; 2024 May-Jun 01; 48(3):436-442. PubMed ID: 38083833
[TBL] [Abstract][Full Text] [Related]
12. A Bayesian approach for diagnostic accuracy of malignant peripheral nerve sheath tumors: a systematic review and meta-analysis.
Martin E; Geitenbeek RTJ; Coert JH; Hanff DF; Graven LH; Grünhagen DJ; Verhoef C; Taal W
Neuro Oncol; 2021 Apr; 23(4):557-571. PubMed ID: 33326583
[TBL] [Abstract][Full Text] [Related]
13. Morphology of the entering and exiting nerve as a differentiating feature of benign from malignant peripheral nerve sheath tumours of the brachial plexus.
Pressney I; Khoo M; Khan R; Abernethy P; Hargunani R; Saifuddin A
Skeletal Radiol; 2021 Aug; 50(8):1557-1565. PubMed ID: 33410965
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
16. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
17. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
18. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Ahlawat S; Blakeley JO; Rodriguez FJ; Fayad LM
Neurology; 2019 Sep; 93(11):e1076-e1084. PubMed ID: 31395668
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
20. Survival outcomes of malignant peripheral nerve sheath tumors (MPNSTs) with and without neurofibromatosis type I (NF1): a meta-analysis.
Lim Z; Gu TY; Tai BC; Puhaindran ME
World J Surg Oncol; 2024 Jan; 22(1):14. PubMed ID: 38191386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
